Table IV.

Effects of topotecan on the growth of cancer cells in combination with DME25.

	3.2 ng/ml		80 ng/ml		2 μg/ml
Topotecan	Control	YZXJ	Control	YZXJ	Control	YZXJ
AGS	7.6±8.6	18.3±3.7	46.0±5.8	65.9±2.6	88.1±2.0	86.5±2.8
MIAPACA2	0.9±0.9	65.6±4.1	39.5±3.3	80.2±2.6	66.1±0.9	91.6±4.5
A549	NC	NC	48.9±4.3	60.0±2.0	68.8±1.3	66.3±1.6
SKOV3	11±0.7	30.2±2.1	38.9±1.1	50.1±2.7	58.2±0.9	62.1±2.8
COV504	NC	23.1±0.8	24.9±5.1	50.12±12.5	39.4±1.8	79.9±2.8
SKMES1	7.8±0.6	40.4±2.8	62.3±1.4	88.4±3.4	50.6±1.1	72.6±2.7